Hamilton Thomas Edward

CIK 00017698482 companiesBALA CYNWYD, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001769848

Recent Transactions

27 trades

Purchase
Larimar Therapeutics, Inc.$LRMR
Common Stock
2026-07-06$3.34/sh+50,000→ 714,798 total
Award
ANNALY CAPITAL MANAGEMENT INC$NLY
Deferred Stock Units
2026-06-10+8,641→ 53,884 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2026-05-19+55,150→ 55,150 total
Purchase
Larimar Therapeutics, Inc.$LRMR
Common Stock
2026-02-27$5.00/sh+100,000→ 664,798 total
Award
ANNALY CAPITAL MANAGEMENT INC$NLY
Deferred Stock Units
2025-05-14+8,961→ 45,243 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2025-05-13+19,000→ 19,000 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2024-05-29+19,000→ 19,000 total
Award
ANNALY CAPITAL MANAGEMENT INC$NLY
Deferred Stock Units
2024-05-15+8,583→ 36,282 total
Purchase
Larimar Therapeutics, Inc.$LRMR
Common Stock
2024-02-16$8.74/sh+57,208→ 564,798 total
Award
ANNALY CAPITAL MANAGEMENT INC$NLY
Deferred Stock Units
2023-05-17+8,167→ 27,698 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2023-05-09+8,300→ 8,300 total
Purchase
Larimar Therapeutics, Inc.$LRMR
Common Stock
2022-09-16$3.15/sh+317,460→ 507,590 total
Award
ANNALY CAPITAL MANAGEMENT INC$NLY
Deferred Stock Units
2022-05-18+24,372→ 78,124 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2022-05-10+8,300→ 8,300 total
Purchase
Larimar Therapeutics, Inc.$LRMR
Common Stock
2021-06-30$8.75/sh+56,710→ 190,130 total
Award
ANNALY CAPITAL MANAGEMENT INC$NLY
Deferred Stock Units
2021-05-19+15,609→ 53,752 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (right to buy)
2021-05-12+8,300→ 8,300 total
Sale
ANNALY CAPITAL MANAGEMENT INC$NLY
Common Stock
2021-05-03$9.18/sh−80,000→ 0 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (right to buy)
2020-09-29+16,600→ 16,600 total
Other
Larimar Therapeutics, Inc.$LRMR
Common Stock
2020-06-26+159,433→ 292,853 total
Other
Larimar Therapeutics, Inc.$LRMR
Common Stock
2020-06-26+133,420→ 133,420 total
Award
ANNALY CAPITAL MANAGEMENT INC$NLY
Deferred Stock Units
2020-05-20+22,551→ 38,143 total
Purchase
ANNALY CAPITAL MANAGEMENT INC$NLY
Common Stock
2020-05-15$5.96/sh+200,000→ 330,000 total
Award
ANNALY CAPITAL MANAGEMENT INC$NLY
Deferred Stock Units
2019-05-22+15,592→ 15,592 total
Purchase
ANNALY CAPITAL MANAGEMENT INC$NLY
Common Stock
2019-05-17$9.47/sh+30,000→ 130,000 total
Purchase
ANNALY CAPITAL MANAGEMENT INC$NLY
Common Stock
2019-05-17$9.47/sh+30,000→ 130,000 total
Purchase
ANNALY CAPITAL MANAGEMENT INC$NLY
Common Stock
2019-05-17$9.47/sh+30,000→ 80,000 total

Companies

Recent Filings

Address

C/O LARIMAR THERAPEUTICS, INC. THREE BALA PLAZA EAST, SUITE 506

BALA CYNWYD, PA, 19004

View on SEC.gov